Thermo Fisher (TMO) is a publicly traded Healthcare sector company. As of October 13, 2026, TMO trades at $661.79 with a market cap of $243.30B and a P/E ratio of 35.37. TMO moved +0.64% today. Year to date, TMO is +14.29%; over the trailing twelve months it is +26.19%. Its 52-week range spans $385.46 to $694.33. Analyst consensus is strong buy with an average price target of $673.63. Rallies surfaces TMO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
18 analysts cover TMO: 0 strong buy, 15 buy, 3 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $673.63.
| Metric | Value |
|---|---|
| Price | $661.79 |
| Market Cap | $243.30B |
| P/E Ratio | 35.37 |
| EPS | $18.61 |
| Dividend Yield | 0.47% |
| 52-Week High | $694.33 |
| 52-Week Low | $385.46 |
| Volume | 950.85K |
| Avg Volume | 0 |
| Revenue (TTM) | $46.34B |
| Net Income | $6.99B |
| Gross Margin | 0.00% |
18 analysts cover TMO: 0 strong buy, 15 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $673.63.